Brief summary on pathogenic mechanism of Ebola virus

doi:10.3969/j.issn.1006-7795.2014.05.001

Abstract

Abstract:

The Ebola virus (EBOV), a single strand negative RNA virus, belongs to Family Filoviridae. The infection can cause severe haemorrhagic fever (EHF). The virus distributes widely in Africa mainland and has caused continuous outbreaks because of its strong virulence and high infectivity. However, the pathogenesis of EHF remains unknown. This review will focus on recent progress of Ebola research to provide information for prevention and treatment of EBOV infection.

Key words: Ebola virus, haemorrhagic fever, pathogenesis

CLC Number:

R512.8

Sheng Ziyang, Fan Dongying, An Jing. Brief summary on pathogenic mechanism of Ebola virus[J]. Journal of Capital Medical University, 2014, 35(5): 529-532.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: https://journal03.magtech.org.cn/Jweb_sdykdxxb/EN/10.3969/j.issn.1006-7795.2014.05.001

https://journal03.magtech.org.cn/Jweb_sdykdxxb/EN/Y2014/V35/I5/529

References

[1] Leroy E M, Baize S, Volchkov V E, et al. Human asymptomatic Ebola infection and strong inflammatory response[J]. Lancet, 2000, 355(9222): 2210-2215.
[2] WHO. Ebola virus disease; Fact sheet N°103. [EB/OL] [2014-09-10]. http://www.who.int/mediacentre/factsheets/fs103/en/.).
[3] Sullivan N, Yang Z Y, Nabel G J. Ebola virus pathogenesis: implications for vaccines and therapies[J]. J virology, 2003, 77(18): 9733-9737.
[4] Geisbert T W, Hensley L E, Larsen T, et al. Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection[J]. Am J Pathol, 2003, 163(6):2347-2370.
[5] Davis K J, Anderson A O, Geisbert T W, et al. Pathology of experimental Ebola virus infection in African green monkeys[J]. Involvement of fibroblastic reticular cells. Arch Pathol Labo Med, 1997, 121(8): 805-819.
[6] Feldmann H, Bugany H, Mahner F, et al. Filovirus-induced endothelial leakage triggered by infected monocytes/macrophages[J]. J Virology, 1996, 70(4): 2208-2214.
[7] Geisbert T W, Young H A, Jahrling P B, et al. Pathogenesis of Ebola hemorrhagic fever in primate models: evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells[J]. Am J Pathol, 2003, 163(6): 2371-2382.
[8] Wauquier N, Becquart P, Padilla C, et al. Human fatal zaire ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis[J]. PLoS neglected trop Dis, 2010, 4(10): e837.
[9] Villinger F, Rollin P E, Brar S S, et al. Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection[J]. J Infect Dis, 1999, 179 Suppl 1: S188-191.
[10] Baize S, Leroy E M, Georges A J, et al. Inflammatory responses in Ebola virus-infected patients[J]. Clin Exp Immunol, 2002, 128(1): 163-168.
[11] Sobarzo A, Ochayon D E, Lutwama J J, et al. Persistent immune responses after Ebola virus infection[J]. N Eng J Med, 2013, 369(5): 492-493.
[12] Lubaki N M, Ilinykh P, Pietzsch C, et al. The lack of maturation of Ebola virus-infected dendritic cells results from the cooperative effect of at least two viral domains[J]. J virology, 2013, 87(13): 7471-7485.
[13] Hartman A L, Bird B H, Towner J S, et al. Inhibition of IRF-3 activation by VP35 is critical for the high level of virulence of ebola virus[J]. J virology, 2008, 82(6): 2699-2704.
[14] Basler C F, Mikulasova A, Martinez-Sobrido L, et al. The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3[J]. J virology, 2003, 77(14): 7945-7956.
[15] Mateo M, Reid S P, Leung L W, et al. Ebolavirus VP24 binding to karyopherins is required for inhibition of interferon signaling[J]. J virology, 2010, 84(2): 1169-1175.
[16] Feng Z, Cerveny M, Yan Z, et al. The VP35 protein of Ebola virus inhibits the antiviral effect mediated by double-stranded RNA-dependent protein kinase PKR[J]. J virology, 2007, 81(1): 182-192.
[17] Kash J C, Muhlberger E, Carter V, et al. Global suppression of the host antiviral response by Ebola and Marburgviruses: increased antagonism of the type I interferon response is associated with enhanced virulence[J]. J virology, 2006, 80(6): 3009-3020.
[18] Horvath C J, Ferro T J, Jesmok G, et al. Recombinant tumor necrosis factor increases pulmonary vascular permeability independent of neutrophils[J]. Proc Nat Acad Sci USA, 1988, 85(23): 9219-9223.
[19] Nawroth P P, Bank I, Handley D, et al. Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1[J]. J Exp Med, 1986, 163(6): 1363-1375.
[20] Yang Z Y, Duckers H J, Sullivan N J, et al. Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury[J]. Nature medicine, 2000, 6(8): 886-889.
[21] Wahl-Jensen V, Kurz S, Feldmann F, et al. Ebola virion attachment and entry into human macrophages profoundly effects early cellular gene expression[J]. PLoS Neglected Trop Dis, 2011, 5(10): e1359.